Insulin-based Strategies to Prevent Hypoglycemia During Exercise
NCT02631265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2017-09-13
Summary
It has been reported that insulin basal rate reduction initiated at exercise onset can reduce the hypoglycemic risk during exercise. However, another potentially more efficient strategy to prevent exercise-induced hypoglycemia could be to reduce insulin basal rate a certain time prior to exercise. No study investigated what would be the best timing to initiate such temporary basal insulin reduction. Therefore, the objective of this study will be to compare the efficacy of three strategies to prevent exercise-induced hypoglycemia during a 45 min exercise at 60% VO2peak (moderate intensity): 1) reduce insulin basal rate at the time of exercise; 2) reduce insulin basal rate 20 minutes prior to exercise; 3) reduce insulin basal rate 40 minutes prior to exercise. Investigators hypothesize that the time spent in hypoglycemia will be less when the insulin basal rate is reduced 40 minutes prior to exercise compared to a reduction at the time of exercise. Secondary hypotheses are: 1) Time spent in hypoglycemia will be less when the insulin basal rate is reduced 20 minutes prior to exercise compared to a reduction at the time of exercise; 2) Time spent in hypoglycemia will be less when the insulin basal rate is reduced 40 minutes prior to exercise compared to a reduction 20 minutes prior to exercise.
Conditions
Interventions
- OTHER
-
Exercise 1
Participants will be admitted at IRCM at 14:00. At 15:30, participant's insulin basal rate will be reduced by 80% and participants will perform a 45-minute exercise on the ergocycle at 60% of VO2 peak (moderate intensity). At 16:15, the participant's usual insulin basal rate will be set in the insulin pump and a standardized snack (30g CHO) will be served. At 16:45, the participant will be discharged and will be asked to eat a standardized dinner at home (60g CHO for females and 80g CHO for males).
- OTHER
-
Exercise 2
Participants will be admitted at IRCM at 14:00. At 15:10, participant's insulin basal rate will be reduced by 80%. At 15:30, participants will perform a 45-minute exercise on the ergocycle at 60% of VO2 peak (moderate intensity). At 16:15, the participant's usual insulin basal rate will be set in the insulin pump and a standardized snack (30g CHO) will be served. At 16:45, the participant will be discharged and will be asked to eat a standardized dinner at home (60g CHO for females and 80g CHO for males).
- OTHER
-
Exercise 3
Participants will be admitted at IRCM at 14:00. At 14:50, participant's insulin basal rate will be reduced by 80%. At 15:30, participants will perform a 45-minute exercise on the ergocycle at 60% of VO2 peak (moderate intensity). At 16:15, the participant's usual insulin basal rate will be set in the insulin pump and a standardized snack (30g CHO) will be served. At 16:45, the participant will be discharged and will be asked to eat a standardized dinner at home (60g CHO for females and 80g CHO for males).
Sponsors & Collaborators
-
Institut de Recherches Cliniques de Montreal
lead OTHER
Principal Investigators
-
Rémi Rabasa-Lhoret · Institut de recherches cliniques de Montréal
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2017-09-30
- Completion
- 2017-09-30
Countries
- Canada
Study Locations
More Related Trials
-
The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia
NCT02308293 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Insulin Regimens in Optimally-controlled Patients With DM2.
NCT01627509 ·Status: UNKNOWN
-
Treatment of Hypoglycemia in Type 1 Diabetes
NCT03489967 ·Status: COMPLETED ·Phase: NA
-
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
NCT01283126 ·Status: COMPLETED ·Phase: NA
-
Effect of Hypoglycemia on Sleep
NCT02687893 ·Status: COMPLETED ·Phase: NA
-
HIT on Hypoglycaemic Risk in T1D
NCT05044442 ·Status: COMPLETED ·Phase: NA
-
Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
NCT02868606 ·Status: COMPLETED
-
Hypoglycemia: Physician and Patient Perspectives
NCT01176656 ·Status: COMPLETED
-
Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes
NCT02866435 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3
NCT00742521 ·Status: COMPLETED ·Phase: NA
-
Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec
NCT03497260 ·Status: COMPLETED ·Phase: NA
-
Study of a Primary Care Hypoglycemia Prevention Program
NCT06353217 ·Status: COMPLETED ·Phase: NA
-
The Effects of Antecedent Hypoglycemia or Exercise on the Response of the Brain to Subsequent Hypoglycemia
NCT00600730 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood Flow
NCT02146404 ·Status: COMPLETED ·Phase: NA
-
Sympathetic Nerve Activity During Hypoglycemia and Exercise
NCT00608348 ·Status: COMPLETED ·Phase: NA
-
Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans
NCT04392843 ·Status: COMPLETED ·Phase: NA
-
Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans
NCT01660009 ·Status: TERMINATED ·Phase: NA
-
Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit
NCT00166491 ·Status: COMPLETED ·Phase: NA
-
Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System
NCT01523665 ·Status: COMPLETED
-
Tight Glycemic Control With Intensive Insulin Therapy in PICU
NCT00214916 ·Status: UNKNOWN ·Phase: PHASE2
-
Cerebral Responses to Insulin Induced Hypoglycemia
NCT02747680 ·Status: COMPLETED ·Phase: NA
-
Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring
NCT01714895 ·Status: COMPLETED ·Phase: NA
-
Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients
NCT05752929 ·Status: COMPLETED ·Phase: PHASE4
-
KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients
NCT00115479 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1
NCT00655460 ·Status: UNKNOWN ·Phase: PHASE2